Diabetes treatment coverage, crude in Singapore
Singapore: Diabetes treatment coverage, crude was 57.31 in 2022. ▲ Rising
Diabetes treatment coverage, crude in Singapore, 1990–2022
Source: World Health Organization, Global Health Observatory.
Analysis
In 2022, diabetes treatment coverage, crude in Singapore stood at 57.31. That is the highest value across all 33 years on record.
That represents a change of up 2.4% over ten years.
Over the whole period, diabetes treatment coverage, crude in Singapore peaked at 57.31 in 2022 and was at its lowest, 49.57, in 1990.
That places Singapore 50th out of 198 countries with data for 2022, putting it in the top quarter.
The long-run direction has been consistently rising across the 33 years of available data.
Diabetes treatment coverage, crude in Singapore, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 49.57 | — |
| 1991 | 49.77 | +0.4% |
| 1992 | 49.98 | +0.4% |
| 1993 | 50.23 | +0.5% |
| 1994 | 50.48 | +0.5% |
| 1995 | 50.71 | +0.5% |
| 1996 | 50.94 | +0.4% |
| 1997 | 51.19 | +0.5% |
| 1998 | 51.51 | +0.6% |
| 1999 | 51.91 | +0.8% |
| 2000 | 52.32 | +0.8% |
| 2001 | 52.71 | +0.8% |
| 2002 | 53.11 | +0.8% |
| 2003 | 53.53 | +0.8% |
| 2004 | 53.97 | +0.8% |
| 2005 | 54.37 | +0.7% |
| 2006 | 54.68 | +0.6% |
| 2007 | 54.91 | +0.4% |
| 2008 | 55.1 | +0.4% |
| 2009 | 55.32 | +0.4% |
| 2010 | 55.55 | +0.4% |
| 2011 | 55.76 | +0.4% |
| 2012 | 55.95 | +0.3% |
| 2013 | 56.13 | +0.3% |
| 2014 | 56.3 | +0.3% |
| 2015 | 56.46 | +0.3% |
| 2016 | 56.62 | +0.3% |
| 2017 | 56.8 | +0.3% |
| 2018 | 56.94 | +0.2% |
| 2019 | 57.02 | +0.1% |
| 2020 | 57.15 | +0.2% |
| 2021 | 57.3 | +0.3% |
| 2022 | 57.31 | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 50.63 | 49.57 | 51.91 | 10 |
| 2000s | 54 | 52.32 | 55.32 | 10 |
| 2010s | 56.35 | 55.55 | 57.02 | 10 |
| 2020s | 57.25 | 57.15 | 57.31 | 3 |
Countries ranked near Singapore
- 47 New Zealand 57.78 compare
- 48 Colombia 57.62 compare
- 49 Venezuela, Bolivarian Republic of 57.62 compare
- 51 Palestine, State of 56.65 compare
- 52 Qatar 56.11 compare
- 53 Argentina 56.06 compare
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Heat deaths vs projected death rates 1,924 (2090)
- Un projection of annual infant deaths 13 (2100)
- Population ages 65 and above, female, annual growth rate 5.07 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.0764 units per person (2025)
- Population ages 65 and above, male, annual growth rate 5.66 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0657 units per person (2025)
Frequently asked questions
- What is diabetes treatment coverage, crude in Singapore?
- Diabetes treatment coverage, crude in Singapore was 57.31 in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest diabetes treatment coverage, crude recorded in Singapore?
- The highest recorded value was 57.31 in 2022.
- What is the lowest diabetes treatment coverage, crude recorded in Singapore?
- The lowest recorded value was 49.57 in 1990.
- How does Singapore rank for diabetes treatment coverage, crude?
- Singapore ranks 50th out of 198 countries with data for 2022.
- Is diabetes treatment coverage, crude rising or falling in Singapore?
- Over the last ten years it is up 2.4%. The long-run trend across the full record is rising.
- Where does this Singapore data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diabetes treatment coverage, crude. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).